Search
for
Sort by
Research 541–570 of 1000+
- Screening the Chemical Composition and Bioactivity of <i>Cerasus serrulata</i> Flower Extracts Using Two Extraction Methods
- Unravelling a novel role for cannabidivarin in the modulation of subventricular zone postnatal neurogenesis
- Pu‐erh tea reduces the transmission of CRD‐mediated alopecia risk to offspring
- Skin
- Cutaneous drug reactions
- Camellia sinensis Seed Flavonoids Attenuate UVB-Induced Inflammation and UVA-Induced Photodamage via MAPK/NF-κB and AP-1 Pathways
- Acute Stress-Induced Changes in Follicular Dermal Papilla Cells and Mobilization of Mast Cells: Implications for Hair Growth
- Hyperinnervation inhibits organ-level regeneration in mammalian skin
- Ovarian sex steroid receptors and sex hormones in androgenized rats
- PEG-Dependent Tunable Degradation and Curcumin Release from Curcumin-Based Biomedical Polyurethanes
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Finasteride interferes with prostaglandin-induced CatSper signalling in human sperm
- Fabrication of Novel Omeprazole-Based Chitosan Coated Nanoemulgel Formulation for Potential Anti-Microbia; In Vitro and Ex Vivo Characterizations
- Success and Controversy of Natural Products as Therapeutic Modulators of Wnt Signaling and Its Interplay with Oxidative Stress: Comprehensive Review Across Compound Classes and Experimental Systems
- Repurposing of approved cardiovascular drugs
- Epigenetic regulation and factors that influence the effect of iPSCs-derived neural stem/progenitor cells (NS/PCs) in the treatment of spinal cord injury
- Minoxidil-induced hypertrichosis: Pathophysiology, clinical implications, and therapeutic strategies
- Signal Peptide-CUB-EGF-like Domain-Containing Protein 3 (SCUBE3): From Molecule to Therapy
- Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- Distinct mechanisms for sebaceous gland self-renewal and regeneration provide durability in response to injury
- Genetic Analysis of Male Pattern Baldness and the 5α-Reductase Genes
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- A genome-wide association scan in admixed Latin Americans identifies loci influencing facial and scalp hair features
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- 5α-Reductase inhibitors in androgenetic alopecia